Table 2.
A summary of the published cases of chylothorax after coronary artery bypass grafting where octreotide was used in the management.
| Author | Procedure | Age/Gender | LIMA/RIMA | Site | Surgery to diagnosis duration (days) | Management and Use of Octreotide/Somatostatin |
|---|---|---|---|---|---|---|
| Perez et al., 1999 [26] | CABG +AVR | 68 y/M | UK | L & M | 10 | Chest tube drainage, TPN, MCTG, Octreotide, resolved after 10 days |
| Kelly et al., 2000 [27] | CABG | 77 y/M | L | L | 18 | Chest tube drainage, NPO, TPN, Octreotide (50 μg SC TID for 14 days), resolved after 14 days |
| Gabbieri et al., 2004 [28] | CABG | 67 y/F | LIMA | L | 10 | Chest tube drainage, TPN, NPO, Octreotide (100 μg SC TID), resolved after 28 days |
| Kilic et al., 2005 [29] | CABG | 66 y/F | LIMA | L | 12 | Chest tube drainage, MCTG, Octreotide (100 μg SC TID), resolved after 10 days |
| Barbetakis et al., 2006 [30] | CABG | 78 y/M | LIMA | L | 27 | Chest tube drainage, MCTG, Octreotide |
| Altun et al., 2015 [6] | CABG | 60 y/M | LIMA | UK | 2 | Chest tube drainage, NPO, TPN, Somatostatin infusion @ 3.5 μg/kg/Hr, increased to 7 μg/Kg/Hr, resolved after 13 days |
| Altun et al., 2015 [6] | CABG | 46 y/M | LIMA | UK | 3 | Chest tube drainage, NPO, TPN, Somatostatin infusion, resolved after 7 days |
| Owais et al., 2015 [31] | CABG | 76 y/F | LIMA | L | 15 | Chest tube drainage, MCTG, Octreotide (100 μg SC 8 hourly), resolved after 7 days |
| Waikar et al., 2018 [24] | CABG | 52 y/M | LIMA | L | 6 | Chest tube drainage, NPO, TPN, later on MCTG, Octreotide (100 μg SC 8 hourly), pleurodesis done with 7.5% povidone iodine on POD 11th, resolved after 14 days |
| Mukherjee et al., 2016 [32] | CABG | 56 y/M | LIMA | L | 3 | Chest tube drainage, Octreotide, Tal pleurodesis after 30 days of conservative management, lung expanded after two days of pleurodesis |
| Mukherjee et al., 2016 [32] | CABG | 50 y/M | LIMA | L | 14 | Chest tube drainage, Octreotide, Tal pleurodesis after 29 days of conservative management |